News for Biocartis Group NV (BIOGF)

BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 09 May 2024, 07:00 CEST Biocartis Group NV provides an update...

BIOCARTIS GROUP NV (Euronext Brussels: BCART) PERSBERICHT - GEREGULEERDE INFORMATIE - 09 mei 2024, 07:00 CEST Biocartis Group NV brengt een update rond de...

BIOCARTIS GROUP NV PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency notification 1. Summary of notice BIOCARTIS GROUP NV received a...

PRESS RELEASE - 22 November 2023, 10:00 CET BIOCARTIS HOLDINGS INC. RECAPITALIZATION COMPLETED AND PRODUCT PORTFOLIO EXPANSION The recapitalization of...

PERSBERICHT - GEREGULEERDE INFORMATIE - 31 oktober 2023, 15:30 CET MEDEDELING BETREFFENDE UITWINNING DOOR GEWAARBORGDE SCHULDEISERS De Secured Creditors...

The global point-of-care molecular diagnostics market is growing at a CAGR of 13.4% from 2021 to 2028....

PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress...

PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Mechelen, Belgium, 16 October 2023 – Biocartis Group NV , an...

PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Mechelen, Belgium, 16...

PERSBERICHT 16 oktober 2023, 7:00 CEST Biocartis steunt Borstkankermaand met lancering van een borstkankerportfolio Mechelen, België, 16 oktober 2023 -...

/PRNewswire/ -- The "Global Prenatal and New-born Genetic Testing Market (2022-2027) by Type, Technology, Application, and Geography, Competitive Analysis and...

/PRNewswire/ -- The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025" report...

PRESS RELEASE REGULATED INFORMATION ... | September 2, 2021

PRESS RELEASE:  REGULATED INFORMATION2 September 2021, 07:01 CEST         BIOCARTIS ANNOUNCES H1 2021 RESULTS H1 2021 results: Very strong growth with...